2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
15
Prostatic Neoplasms
10
Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
4
Triple Negative Breast Neoplasms
3
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Endometrial Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Cardiovascular Diseases
3
Cardiotoxicity
3
Rectal Neoplasms
2
Polycystic Ovary Syndrome
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Leukemia
2
Kidney Neoplasms
2
Heart Failure
2
Head and Neck Neoplasms
2
Glioblastoma
2
Endometrial Hyperplasia
2
Carcinoma, Renal Cell
2
Waldenstrom Macroglobulinemia
1
Venous Thrombosis
1
Urogenital Neoplasms
1
Smoking
1
Interventions
Metformin
8
Surveys and Questionnaires
3
Pioglitazone
3
Nutrition Assessment
3
Methods
3
Exercise
3
Educational Status
3
Tirzepatide
2
Therapeutics
2
Tablets
2
Standard of Care
2
Specimen Handling
2
Resistance Training
2
Interviews as Topic
2
Glucose Tolerance Test
2
Biopsy
2
tocilizumab
1
tislelizumab
1
sofosbuvir-velpatasvir drug combination
1
saxagliptin
1
pembrolizumab
1
otelixizumab
1
nabiximols
1
esmolol
1
epalrestat
1
donafenib
1
dapagliflozin
1
amlodipine, atorvastatin drug combination
1
Verapamil
1
Urine Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diabetes Mellitus
×
Atorvastatin
×
Clear all
NCT02099123
2024-11-21
STAREE
Monash University
Phase 4
Active not recruiting
9,971 enrolled